INFLIXIMAB-DYYB

11624 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB-DYYB:

# Side effect Count
0 OFF LABEL USE 5874
1 CONDITION AGGRAVATED 3784
2 INTENTIONAL PRODUCT USE ISSUE 2813
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2414
4 ARTHRALGIA 1649
5 WEIGHT INCREASED 1629
6 DRUG INEFFECTIVE 1626
7 BLOOD PRESSURE FLUCTUATION 1488
8 WEIGHT DECREASED 1456
9 FATIGUE 1365
See all common reactions for INFLIXIMAB-DYYB

INFLIXIMAB-DYYB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAECAL CALPROTECTIN DECREASED 9 0.2571
1 TREATMENT DELAYED 36 0.2432
2 FAECAL CALPROTECTIN INCREASED 305 0.2213
3 DRUG LEVEL BELOW THERAPEUTIC 553 0.1622
4 WHITE COAT HYPERTENSION 25 0.1238
5 DRUG LEVEL ABOVE THERAPEUTIC 271 0.0995
6 FAECAL CALPROTECTIN ABNORMAL 14 0.0966
7 ANAL FISTULA INFECTION 9 0.0957
8 BODY TEMPERATURE FLUCTUATION 148 0.0931
9 ANAL FISSURE 265 0.0922
See all enriched reactions for INFLIXIMAB-DYYB